DOP14: Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international studyECCO'24Year: 2024
Authors: Mol, B.(1)*;van Nieuwamerongen, M.(1);Färkkilä, M.(2);Folseraas, T.(3);Boberg, K.(3);Vesterhus, M.(4);Bergquist, A.(5);Bogaards, H.(6);Ponsioen, C.(1);
(1)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Helsinki University Hospital, Gastroenterology and Hepatology, Helsinki, Finland;(3)Oslo University Hospital, Norwegian PSC Research Centre- Department of Transplantation Medicine, Oslo, Norway;(4)University of Bergen, Medicine- Haraldsplass Deaconess Hospital and Department of Clinical Science, Bergen, Norway;(5)Karolinska University Hospital, Gastroenterology and Rheumatology, Stockholm, Sweden;(6)Amsterdam UMC, Epidemiology and Data Science, Amsterdam, The Netherlands;EpiPSC2
DOP15: Results of a pragmatic multicentred randomised controlled trial investigating the use of personalised golimumab dosing in Ulcerative Colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis)ECCO'24Year: 2024
Authors: Doherty, G.(1)*;Coe, C.(1);Egan, L.(2);Kevans, D.(3);O@E@Toole, A.(4);Cullen , G.(1);Galligan, M.(5);McCarthy, J.(6);Slattery, E.(2);McShane, C.(7);O@E@Connell, J.(7);Mulcahy, H.(1);Leyden, J.(8);Godwin, N.(4);Keogh, A.(9);Patchett, S.(4);Sheridan, J.(1);
(1)St Vincent@E@s University Hospital and University College Dublin, Department of Gastroenterology and School of Medicine, Dublin, Ireland;(2)University Hospital and University of Galway, Department of Gastroenterology and School of Medicine, Galway, Ireland;(3)St James@E@ Hospital and Trinity College Dublin, School of Medicine, Dublin, Ireland;(4)Beaumont Hospital and Royal College of Surgeons in Ireland, Department of Gastroenterology and School of Medicine, Dublin, Ireland;(5)University College Dublin, School of Medicine, Dublin, Ireland;(6)Mercy University Hospital and University College Cork, Department of Gastroenterology and School of Medicine, Dublin, Ireland;(7)St James@E@ Hospital and Trinity College Dublin, Department of Gastroenterology and School of Medicine, Dublin, Ireland;(8)Mater Misericordiae University Hospital and University College Dublin, GI Unit and School of Medicine, Dublin, Ireland;(9)Uniiversity Hospital and University of Galway, Department of Gastroenterology and School of Medicine, Galway, Ireland;INITIATIVE network (www.initiativeibd.ie)
DOP16: Safety of long-term ozanimod treatment for up to 4 years in patients with moderately to severely active Ulcerative Colitis: an interim analysis of the True North open-label extensionECCO'24Year: 2024
Authors: Siegel, C.(1)*;Danese, S.(2);Rubin, D.T.(3);Sabino, J.(4);Long, M.D.(5);Cross, R.K.(6);Armuzzi, A.(7,8);Blumenstein, I.(9);Kobayashi, T.(10);Lama, S.(11);Charles, L.(11);Cetin, V.(11);Petersen, A.(11);Wu, H.(11);Wang, D.(12);Jain, A.(11);D@E@Haens, G.(13);
(1)Dartmouth-Hitchcock Clinic, Gastroenterology, Lebanon, United States;(2)Department of Gastroenterology and Endoscopy- IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Gastroenterology and Endoscopy, Milan, Italy;(3)University of Chicago Medicine- Inflammatory Bowel Disease Center, Inflammatory Bowel Diseases, Chicago, United States;(4)Department of Gastroenterology- University Hospitals Leuven-, Gastroenterology, Leuven, Belgium;(5)UNC Chapel Hill, Gastroenterology and Hepatology, Chapel Hill, United States;(6)University of Maryland School of Medicine, Gastroenterology and Hepatology, Baltimore, United States;(7)IBD Center- IRCCS Humanitas Research Hospital- Rozzano, Inflammatory Bowel Disease, Milan, Italy;(8)Department of Biomedical Sciences- Humanitas University- Pieve Emanuele, Department of Biomedical Sciences, Milan, Italy;(9)Goethe University Hospital, Inflammatory Bowel Disease, Frankfurt, Germany;(10)Kitasato University Kitasato Institute Hospital, Gastroenterology, Tokyo, Japan;(11)Bristol Myers Squibb, n/a, Princeton, United States;(12)Bristol Myers Squibb K. K., n/a, Tokyo, Japan;(13)Amsterdam University Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands;
DOP17: Tofacitinib versus Vedolizumab Among Bio-naïve Patients With Ulcerative Colitis: A Real-World Propensity-Weighted ComparisonECCO'24Year: 2024
Authors: Gros, B.(1,2)*;Constantine-Cooke, N.(3,4);Kennedy, J.(5);Elford, A.T.(5,6);O’Hare, C.(5,7);Noble, C.(5);Jones, G.R.(5,8);Arnott, I.D.(5);Plevris, N.(5);Lees, C.W.(4,5);
(1)Western General Hospita, Edinburgh IBD Unit, Edinburgh, United Kingdom;(2)Reina Sofía University Hospital, Gastroenterology and Hepatology, Cordoba, Spain;(3)Western General Hospital, MRC Human Genetics Unit- Institute of Genetics and Cancer- University of Edinburgh, Edinburgh, United Kingdom;(4)Western General Hospital, Centre for Genomics and Experimental Medicine- Institute of Genetics and Cancer- University of Edinburgh, Edinburgh, United Kingdom;(5)Western General Hospital, Edinburgh IBD Unit, Edinburgh, United Kingdom;(6)The University of Melbourne, Faculty of Medicine, Melbourne, Australia;(7)Western General Hospital, Edinburgh Pharmacy Unit, Edinburgh, United Kingdom;(8)University of Edinburgh, Centre for Inflammation Research- The Queen@E@s Medical Research Institute-, Edinburgh, United Kingdom;
DOP18: Efficacy of risankizumab versus ustekinumab by baseline Crohn’s Disease location: post-hoc analysis of the SEQUENCE head-to-head trialECCO'24Year: 2024
Authors: Peyrin-Biroulet, L.(1)*;Colombel, J.F.(2);D’Haens, G.(3);Dubinsky, M.(2);Cao, Q.(4);Kligys, K.(5);Garrison, A.(5);Huang, X.(5);Neimark, E.(5);Anschutz, T.(5);Crowley, J.(5);Panaccione, R.(6);
(1)Nancy University Hospital, Department of Gastroenterology, Vandœuvre-lès-Nancy, France;(2)Icahn School of Medicine at Mt. Sinai, Department of Gastroenterology, New York, United States;(3)Amsterdam UMC campus AMC, Department of Gastroenterology, Amsterdam, Netherlands Antilles;(4)Inflammatory Bowel Disease Center- Sir Run Run Shaw Hospital- College of Medicine Zhejiang University, Department of Gastroenterology, Hangzhou, China;(5)AbbVie Inc., Research and Development, North Chicago, United States;(6)University of Calgary, Inflammatory Bowel Disease Unit- Division of Gastroenterology and Hepatology, Calgary, Canada;
DOP19: High dimensional profiling of IL-23-responsive cells revealed molecular signatures that predict response to anti-IL-23 therapy in patients with Crohn’s DiseaseECCO'24Year: 2024
Authors: Cao, S.(1)*;Colonna, M.(2);Deepak, P.(3);
(1)Washington University in St. Louis, Gastroenterology, St. Louis, United States;(2)Washington University, Pathology and Immunology, St. Louis, United States;(3)Washington University, Gastroenterology, St. Louis, United States;
DOP20: Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Bourgonje, A.R.(1,2)*;Andreu-Sánchez, S.(3);Gacesa, R.(2);Klompus, S.(4);Kalka, I.N.(4);Leviatan, S.(4);Weinberger, A.(4);Segal, E.(4);Fu, J.(3);Zhernakova, A.(3);Vogl, T.(5);Weersma, R.K.(2);
(1)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(2)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(3)University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands;(4)Weizmann Institute of Science, Department of Computer Science and Applied Mathematics and Department of Molecular Cell Biology, Rehovot, Israel;(5)Medical University of Vienna, Center for Cancer Research, Vienna, Austria;Lifelines Cohort Study
DOP21: Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy RiskECCO'24Year: 2024
Authors: Lenfant, M.(1,2)*;De Hertogh, G.(3);Sabino, J.(1,2);Verstockt, B.(1,2);Ferrante, M.(1,2);Vermeire, S.(1,2);
(1)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing / Translational Research in Gastrointestinal Disorders TARGID, Leuven, Belgium;(3)University Hospitals Leuven, Department of Pathology, Leuven, Belgium;
DOP22: Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.ECCO'24Year: 2024
Authors: Baldan-Martin, M.(1)*;Azkargorta, M.(2);Aransay, A.M.(3);Gil-Redondo, R.(4);Moreno-Indias, I.(5);Iloro, I.(2);Soleto, I.(1);Orejudo, M.(1);Ramírez , C.(1);Lucendo, A.J.(6);Rodríguez Gutiérrez, C.(7);Gutiérrez, A.(8);Martín Arranz, E.(9);Bujanda, L.(10);Rodríguez-Lago, I.(11);Riestra, S.(12);Iglesias-Flores, E.(13);Bermejo, F.(14);Van Domselaar, M.(15);García, M.J.(16);Fernández-Salazar, L.(17);García-Alonso, J.F.(18);Calvet, X.(19);Torrealba, L.(20);Bastón Rey, I.(21);Pallarés, H.(22);Ber, Y.(23);Carnerero, E.L.(24);Casanova , M.J.(1);Millet, Ó.(4);Elortza, F.(2);Mato, J.M.(4);Tinahones, F.J.(5);Chaparro*, M.(1);Gisbert*, J.P.(1);
(1)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd- Madrid. Spain, Gastroenterology Unit, Madrid Madrid, Spain;(2)CIC bioGUNE- BRTA Basque Research & Technology Alliance- CIBERehd, Proteomics Platform, Derio, Spain;(3)CIC bioGUNE- Basque Research and Technology Alliance BRTA- CIBERehd, Genome Analysis Platform, Derio, Spain;(4)CIC bioGUNE, Precision Medicine and Metabolism Lab, Derio, Spain;(5)Virgen de la Victoria University Hospital- Málaga- Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición CIBEROBN- Instituto de Salud Carlos III, Department of Endocrinology and Nutrition, Madrid, Spain;(6)Hospital General de Tomelloso- Instituto de Investigación Sanitaria de Castilla-La Mancha IDISCAM- CIBERehd, Gastroenterology Unit, Ciudad Real, Spain;(7)Hospital Universitario de Navarra, Gastroenterology Unit, Pamplona, Spain;(8)Hospital General Universitario de Alicante- CIBERehd and Instituto Investigación Sanitaria y Biomédica de Alicante, Gastroenterology Unit, Alicante, Spain;(9)Hospital Universitario La Paz and Instituto de Investigación Sanitaria La Paz IdiPaz- UAM, Gastroenterology Unit, Madrid, Spain;(10)Hospital Universitario Donostia and Instituto Biodonostia. Universidad del País Vasco UPV/EHU, Gastroenterology Unit, Donostia, Spain;(11)Hospital Universitario de Galdakao- Biocruces Bizkaia HRI, Gastroenterology Unit, Vizcaya, Spain;(12)Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Gastroenterology Unit, Oviedo, Spain;(13)Hospital Universitario Reina Sofia, Gastroenterology Unit, Córdoba, Spain;(14)Hospital Universitario de Fuenlabrada, Gastroenterology Unit, Madrid, Spain;(15)Hospital Universitario de Torrejón, Gastroenterology Unit, Madrid, Spain;(16)Hospital Universitario Marqués de Valdecilla and IDIVAL, Gastroenterology and Hepatology Unit, Santander, Spain;(17)Hospital Clínico Universitario de Valladolid, Gastroenterology Unit, Valladolid, Spain;(18)Hospital Universitario Rio Hortega. Valladolid, Gastroenterology Unit, Valladolid, Spain;(19)Consorci Corporació Santitària Parc Taulí- CIBERehd. Sabadell, Gastroenterology Unit, Sabadel, Spain;(20)Hospital Universitario Dr. Josep Trueta, Gastroenterology Unit, Girona, Spain;(21)Hospital Clínico Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain;(22)Hospital Juan Ramón Jiménez, Gastroenterology Unit, Huelva, Spain;(23)Hospital San Jorge, Gastroenterology Unit, Huesca, Spain;(24)Hospital Universitario Virgen del Rocío, Gastroenterology Unit, Sevilla, Spain;*Authors share co-senior authorship.
DOP23: The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohortECCO'24Year: 2024
Authors: ReenaersDr, C.(1)*;Enea, D.(2);Nachury, M.(3);Laharie, D.(4);Bouhnik, Y.(5);Fumery, M.(6);Gornet, J.M.(7);Amiot, A.(8);Altwegg, R.(9);de Vos , M.(10);Marteau, P.(11);Bourreille, A.(12);Nancey, S.(13);Viennot, S.(14);Louis, E.(15);svrcek, M.(2);
(1)CHU Liège- Sart Tilman, Department of Gastroenterology, Liège, Belgium;(2)Hospital Saint-Antoine, Pathology, Paris, France;(3)CHU Lille, Gastroenterology, Lille, France;(4)CHU Bordeaux, Gastroenterology, Bordeaux, France;(5)Institut des MICI, Gastroenterology, Neuilly-sur-Seine, France;(6)CHU Amiens, Gastroenterology, Amiens, France;(7)Hospital Saint-Louis, Gastroenterology, Paris, France;(8)Kremelin-Bicètre, Gastroenterology, Paris, France;(9)CHU Montpellier, Gatroenterology, Montpellier, France;(10)UZ Ghent, Gastroenterology, Ghent, Belgium;(11)Hospital Saint-Antoine, Gastroenterology, Paris, France;(12)CHU Nantes, Gastroenterology, Nantes, France;(13)CHU Lyon, Gastroenterology, Lyon, France;(14)Clinique de l@E@Alma, Gastroenterology, Paris, France;(15)CHU Liège- Sart Tilman, Gastroenterology, Liège, Belgium;GETAID
DOP24: Multi-omic sequencing reveals distinctive gene expression and DNA methylation alterations as potential predictors of primary sclerosing cholangitis development in treatment-naïve paediatric Ulcerative ColitisECCO'24Year: 2024
Authors: Rodriguez Sosa, A.(1)*;Lawal, O.(1);McDonnell, C.(1);Grant, L.(1);Stephens, I.(1);Genua, F.(1);O@E@Brien, J.(1);Kirwan, G.(1);Kel, A.(2);Dominik, A.(3);Stack, R.(4);Yochum, G.(5);Doherty, G.(6);Hussey, S.(7);Das, S.(1);
(1)Royal College of Surgeons in Ireland, School of Pharmacy and Biomolecular Sciences, Dublin, Ireland;(2)Children@E@s Health Ireland- Crumlin, Department of Pahtology, Crumlin, Ireland;(3)GeneXplain, GmbH, Germany, Germany;(4)st vincent@E@s university hospital and university college Dublin, Center for Colorectal Disease, Dublin, Ireland;(5)Department of Surgery- Division of Colon and Rectal Surgery- Department of Biochemistry & Molecular Biology- The Pennsylvania State University- College of Medicine- PA- USA, Department of Surgery- Division of Colon and Rectal Surgery, Pennsylvania, United States;(6)St. Vincent’s University Hospital and University College Dublin, Center for Colorectal Disease, Dublin, Ireland;(7)DOCHAS Study Children@E@s Health Ireland, Department of Paediatrics UCD, Dublin, Ireland;
DOP25: Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative ColitisECCO'24Year: 2024
Authors: Mendieta Escalante, E.A.(1)*;Parada-Venegas, D.(2);Roozendaal, C.(3);Hermoso, M.(2);Bourgonje, A.R.(2);Faber, K.N.(2);Gerard , D.(4);
(1)University Medical Center of Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands;(2)UMCG, Gastroenterology and Hepatology, Groningen, The Netherlands;(3)UMCG, Department of Laboratory Medicine, Groningen, The Netherlands;(4)UMCG, Gastreoenterology and Hepatology, Groningen, The Netherlands;
DOP26: Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohortECCO'24Year: 2024
Authors: Marius, B.(1)*;Rolhion, N.(1);Creusot, L.(1);Lefevre, A.(2);Alonso, I.(1);Brot, L.(1);Danne, C.(1);Bourrier, A.(3);Parrot, L.(3);Mélanie, D.(3);Benech, N.(3);Nion-Larmurier, I.(3);Mclellan, P.(3);Landman, C.(3);Beaugerie, L.(3);Seksik, P.(1);Emond, P.(2);Kirchgesner, J.(2);Sokol, H.(1);
(1)Sorbonne Université- Centre de Recherche Saint-Antoine- CRSA, Inserm UMRS-938, Paris, France;(2)University of Tours- Inserm, UMR 1253- iBrain, Tours, France;(3)Saint Antoine Hospital- APHP, Gastroenterology department, Paris, France;
DOP27: Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn@E@s Disease and chronic fatigue syndromeECCO'24Year: 2024
Authors: Bourgonje, A.R.(1,2)*;Hörstke, N.V.(3);Fehringer, M.(3);Innocenti, G.(3);Vogl, T.(3);
(1)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(2)University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands;(3)Medical University of Vienna, Center for Cancer Research, Vienna, Austria;
DOP28: Yield of surveillance colonoscopy in patients with Primary Sclerosing CholangitisECCO'24Year: 2024
Authors: Van De Pol, N.(1)*;Mol, B.(2);de Jong, M.J.(1);Weersma, R.K.(3);Inderson, A.(4);Slooter, F.C.(2);Gibbes, L.A.(2);van der Meer, A.J.(1);Derikx, L.A.A.P.(1);Ponsioen, C.Y.(2);de Vries, A.C.(1);
(1)Erasmus University Medical Center, Gastroenterology and hepatology, Rotterdam, The Netherlands;(2)Amsterdam University Medical Center, Gastroenterology and hepatology, Amsterdam, The Netherlands;(3)University Medical Center Groningen, Gastroenterology and hepatology, Groningen, The Netherlands;(4)Leiden University Medical Center, Gastroenterology and hepatology, Leiden, The Netherlands;on behalf of the EpiPSC2 Study Group
DOP29: Capsule endoscopy-guided proactive treatment versus standard treatment of patients with quiescent Crohn’s Disease: The CURE-CD randomized controlled trialECCO'24Year: 2024
Authors: Ben-Horin, S.(1)*;Lahat, A.(2);Ungar, B.(2);Ukashi, O.(2);Yablecovitch, D.(2);Amitai, M.M.(3);Haberman, Y.(4);Selinger, L.(2);Talan-Asher, A.(2);Kriger-Sharabi, O.(5);Naftali, T.(6);Ron, Y.(7);Yanai, H.(8);Dotan, I.(8);Kopylov, U.(2);Eliakim, R.(2);
(1)Tel-HaShomer Sheba Medical Center, Department of Gastroenterology, Ramat Gan, Israel;(2)Sheba Medical Center- Tel-Avivi University, Gastroenterology, Ramat Gan, Israel;(3)Sheba Medical Center- Tel-Avivi University, Radiology, Ramat Gan, Israel;(4)Sheba Medical Center- Tel-Avivi University, Gastroenterology, Ramat Ganisra, Israel;(5)Assuta Medical Center, Gastroenterology, Ashdod, Israel;(6)Meir Medical Center, Gastroenterology, Kfar Saba, Israel;(7)Tel Aviv Medical Center, Gastroenterology, Tel-Aviv, Israel;(8)Rabin Medical Center, Gastroenterology, Petah-Tiqwa, Israel;The Israeli IBD Research Nucleus (IIRN)
DOP30: Cross-ethnic microbiome analyses identify shared and specific signals for Northern Indian IBD patientsECCO'24Year: 2024
Authors: Singh, A.(1);Gacesa, R.(2)*;Juyal, G.(3);Joshi, M.(4);Midah, V.(5);Thelma, B.K.(6);Weersma, R.K.(2);Sood, A.(1);
(1)Dayanand Medical College & Hospital, Department of Gastroenterology, Ludhiana, India;(2)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(3)School of Engineering and Applied Sciences- Bennett University, Department of Biotechnology, Greater Noida, India;(4)Jamia Millia Islamia, Multidisciplinary Centre for Advance Research and Studies MCARS, New Delhi, India;(5)Dayanand Medical College & Hospital, Department of Internal Medicine, Ludhiana, India;(6)University of Delhi South Campus, Department of Genetics, New Delhi, India;
DOP31: Gene correlation network analyses reveal transcript modules and pathogenic mechanisms associated with resistance and response to ustekinumab therapy in Ulcerative ColitisECCO'24Year: 2024
Authors: Saifuddin, A.(1)*;Cozzetto, D.(1);Olbei, M.(1);Hart, A.(2);Korcsmaros, T.(1);Powell, N.(1);
(1)Imperial College London, Department of Metabolism- Digestion and Reproduction, London, United Kingdom;(2)St Mark@E@s Academic Institute, Inflammatory Bowel Disease, London, United Kingdom;
DOP32: CD226+TIGITneg expression identifies pathogenic inflammatory CD4+ memory T cells in severe Crohn’s Disease patients, opening up opportunities for patient-tailored treatment strategies.ECCO'24Year: 2024
Authors: Barendregt, D.(1)*;Heredia, M.(1);Tindemans, I.(1);Klomberg, R.C.W.(2);Calado, B.(1);Hulleman-van Haaften, D.H.(1);Bastiaan, T.(1);van Berkel, L.A.(1);Escher, J.C.(2);de Ridder, L.(2);Samsom, J.N.(1);
(1)Erasmus University Medical Center-Sophia Children’s Hospital, Laboratory of Pediatrics, Rotterdam, The Netherlands;(2)Erasmus University Medical Center-Sophia Children’s Hospital, Department of Pediatric Gastroenterology, Rotterdam, The Netherlands;PIBD-SETQuality Consortium
DOP33: Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Bourgonje, A.R.(1)*;Ibing, S.(2,3);Argmann, C.(4);Sands, B.E.(1);Dubinsky, M.(1);Jacobsen, H.A.(5);Suarez-Farinas, M.(6);Mehandru, S.(1);Colombel, J.F.(1);Ungaro, R.C.(1);
(1)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(2)Icahn School of Medicine at Mount Sinai, Hasso Plattner Institute for Digital Health at Mount Sinai, New York, United States;(3)University of Potsdam, Hasso Plattner Institute- Digital Engineering Faculty, Potsdam, Germany;(4)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States;(5)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease- PREDICT- Department of Clinical Medicine- The Faculty of Medicine, Aalborg, Denmark;(6)Icahn School of Medicine at Mount Sinai, Center of Biostatistics, New York, United States;
